AnalystsPeter WelfordPeter Welford's Stock Forecasts
AnalystsPeter Welford
Sectors:
Industries:
Analyst Ranking
Bottom 17%
#4125 out of 4922 analysts
Average Return
-16.05%
Win Rate
50%3 out of 6
Risk vs Reward
Poor
Good
Peter Welford Analyst Color
Get additional color on Peter Welford's coverage of popular stocks
Peter Welford's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Novartis AgNVS | 1 | Strong Buy | $122.50 | +2.07% | Maintains | a year ago |
Gsk PLCGSK | 2 | Strong Buy | $53.00 | +37.38% | Maintains | a year ago |
Astrazeneca PLCAZN | 1 | Strong Buy | $80.00 | N/A | Upgrades | 2 years ago |
Galapagos NvGLPG | 2 | Hold | $47.20 | N/A | Upgrades | 2 years ago |
Barinthus Biotherapeutics PLCBRNS | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 4 years ago |
Celgene CorpCELG | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.